Syndexa Pharmaceuticals' Series B - II Round

Syndexa Pharmaceuticals raised a round of funding on April 11, 2011. Investors include Dr. Yalcin Ayasli.

Syndexa Pharmaceuticals is dedicated to the discovery and development of drugs targeting biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes…

Articles about Syndexa Pharmaceuticals' Series B - II Round: